NeuroPace (NPCE) said Friday it has priced a public offering of 6.5 million shares at $10 per share.
Gross proceeds from the offering, expected to close on Feb. 18, are expected to be $65 million, the company said.
NeuroPace said it has also granted underwriters a 30-day option to purchase up to 975,000 additional shares.
The company said it expects to use around $49.5 million of net proceeds from the offering to acquire 5.3 million shares held by KCK at $9.40 per share, and the remainder for general corporate purposes.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.